Δ9-THC |
Δ9-tetrahydrocannabinol |
2-AG |
2-arachidonoylglycerol |
AEA |
anandamide |
BCRP |
breast cancer resistant protein |
CB1 |
cannabinoid receptor type 1 |
CB2 |
cannabinoid receptor type 2 |
CBD |
cannabidiol |
CBN |
cannabinol |
CNS |
central nervous system |
DOHaD |
developmental origins of health and disease |
eCB |
endocannabinoid |
EPCAM |
epithelial cell adhesion molecule |
ER |
endoplasmic reticulum |
FAAH |
fatty acid amide hydrolase |
FGR |
fetal growth restriction |
GR |
glucocorticoid receptor |
Glut1 |
glucose transporter 1 |
GPCR |
g protein-coupled receptor |
GPR |
orphan G protein-coupled receptor |
HUVEC |
human umbilical vein endothelial cells |
IUGR |
intrauterine growth restriction |
MAM |
mitochondrial-associated ER membrane |
mtCB1
|
mitochondrial cannabinoid receptor type 1 |
NAFLD |
non-alcoholic liver disease |
NAPE-PLD |
N-acylphosphatidylethanolamine-specific phospholipase D |
P-gp |
P-glycoprotein |
ROS |
reactive oxygen species |
T2D |
type II diabetes |
VEGFR-1 |
vascular endothelial growth factor 1 |